WG
GBT

Winton Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Winton Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,528
Closed -$1.4M – 1077
2022
Q3 		$1.4M Sell
20,528
-2,869
-12% -$158K 0.09% 309
2022
Q2 		$748K Buy
23,397
+3,812
+19% +$112K 0.04% 581
2022
Q1 		$678K Sell
19,585
-4,598
-19% -$137K 0.04% 591
2021
Q4 		$708K Buy
24,183
+14,458
+149% +$448K 0.04% 573
2021
Q3 		$248K Sell
9,725
-8,512
-47% -$250K 0.01% 1172
2021
Q2 		$639K Buy
18,237
+2,434
+15% +$95K 0.03% 781
2021
Q1 		$644K Buy
+15,803
New +$726K 0.04% 734
2020
Q4 		– Sell
-18,750
Closed -$1.03M – 1576
2020
Q3 		$1.03M Buy
+18,750
New +$1.19M 0.03% 813

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Winton Group's GBT Position: Q4 2022 in Review

Winton Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 20,528 shares — an estimated $1.4M sold.

Winton Group first reported a position in GBT in Q3 2020 and held it in 8 quarters. The position peaked at $1.4M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Winton Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Winton Group sold 20,528 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.4M.
  • Winton Group first reported a position in Global Blood Therapeutics, Inc. in Q3 2020 and held it in 8 quarters.
  • Winton Group's Global Blood Therapeutics, Inc. position peaked at $1.4M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Winton Group's 13F filing for Q4 2022, filed 14 Feb 2023.